TOI logo

The Oncology Institute, Inc. Stock Price

NasdaqCM:TOI Community·US$375.0m Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author

TOI Share Price Performance

US$3.79
3.45 (1,016.35%)
176.6% overvalued intrinsic discount
US$1.37
Fair Value
US$3.79
3.45 (1,016.35%)
176.6% overvalued intrinsic discount
US$1.37
Fair Value
Price US$3.79
WaneInvestmentHouse US$1.37
AnalystConsensusTarget US$7.00

TOI Community Narratives

WaneInvestmentHouse·
Fair Value US$1.37 176.6% overvalued intrinsic discount

Fourth Quarter 2024 Financial Highlights

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AnalystConsensusTarget·
Fair Value US$7 45.9% undervalued intrinsic discount

Florida And Nevada Expansions Will Strengthen Community Oncology Care

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
US$7
45.9% undervalued intrinsic discount
Revenue growth
19.54% p.a.
Profit Margin
5.39%
Future PE
24.87x
Share price in 2028
US$5.48

Snowflake Analysis

Slight risk and slightly overvalued.

4 Risks
2 Rewards

The Oncology Institute, Inc. Key Details

US$424.4m

Revenue

US$360.6m

Cost of Revenue

US$63.8m

Gross Profit

US$117.9m

Other Expenses

-US$54.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.58
15.02%
-12.75%
-838.5%
View Full Analysis

About TOI

Founded
2007
Employees
825
CEO
Daniel Virnich
WebsiteView website
theoncologyinstitute.com

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Recent TOI News & Updates

Market Cool On The Oncology Institute, Inc.'s (NASDAQ:TOI) Revenues Pushing Shares 26% Lower

Sep 11
Market Cool On The Oncology Institute, Inc.'s (NASDAQ:TOI) Revenues Pushing Shares 26% Lower

Recent updates

No updates